Fig. 2
Trajectories of FVC in SENSCIS and SENSCIS-ON in (a) patients who received nintedanib in SENSCIS and (b) patients who received placebo in SENSCIS
Fig. 2 | Arthritis Research & Therapy
Trajectories of FVC in SENSCIS and SENSCIS-ON in (a) patients who received nintedanib in SENSCIS and (b) patients who received placebo in SENSCIS